A comprehensive view of Blood Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
AstraZeneca withdrawing its Vaxzevria COVID-19 vaccine globally due to surplus of updated vaccines and dwindling demand; EU marketing authorization for the vaccine also withdrawn by AstraZeneca
Published:
May 08, 2024
by Independent, The (UK) (Online)
|
LA HB883: Allows the provision of data relative to sickle cell disease (EG INCREASE GF EX See Note)
Published:
May 08, 2024
by Louisiana 2024 Regular Session
|
LA HB869: Requires continuing education for the treatment of sickle cell disease for physicians and physician assistants
Published:
May 08, 2024
by Louisiana 2024 Regular Session
|
CA AB2613: Jacqueline Marie Zbur Rare Disease Advisory Council.
Published:
May 08, 2024
by California 2023-2024 Session
|
CO SB042: Sickle Cell Disease Community Outreach & Services
Published:
May 06, 2024
by Colorado 2024 Regular Session
|
Ask us about our R&D/Patents market view